Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zuoxiang Liu

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 12, 2024
[Cardiovascular safety of sitagliptin added to metformin in real world patients with type 2 diabetes]Zuoxiang Liu, Xiaowei Chen, Houyu Zhao, et al.
Expert Review of Vaccines|December 23, 2021
Self-controlled case series design in vaccine safety: a systematic reviewXiaolu Nie, Lu Xu, Yi Bai, et al.
Frontiers in Pharmacology|July 18, 2022
Risk of Fracture With Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis Combining 177 Randomized Controlled Trials With a Median Follow-Up of 26 weeksSanbao Chai, Fengqi Liu, Zhirong Yang, et al.
Expert Review of Vaccines|July 27, 2023
Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in ChinaRuogu Meng, Rui Ma, Jianmei Wang, et al.
Expert Review of Vaccines|August 23, 2025
Post-marketing surveillance for the safety of the quadrivalent human papillomavirus vaccine: a retrospective real-world study in ChinaRuogu Meng, Rui Ma, Jianmei Wang, et al.
British Journal of Clinical Pharmacology|February 15, 2022
Pharmacovigilance in China: Evolution and future challengesHaibo Song, Xiaojing Pei, Zuoxiang Liu, et al.
Chinese Medical Journal|June 20, 2024
Efficacy and dose-response relationships of antidepressants in the acute treatment of major depressive disorders: a systematic review and network meta-analysisShuzhe Zhou, Pei Li, Xiaozhen Lyu, et al.
Sleep|July 9, 2023
Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysisShuzhe Zhou, Pei Li, Xiaozhen Lv, et al.
International Journal of Endocrinology|June 28, 2022
Serum Cortisol, 25 (OH)D, and Cardiovascular Risk Factors in Patients with Type 2 Diabetes MellitusYuxi Jin, Dandan Wei, Pengling Liu, et al.
Frontiers in Endocrinology|September 11, 2025
Effect of levothyroxine on major adverse cardiovascular events in patients with hypothyroidism and cardiovascular diseaseLijia Liu, Haiqing Zhang, Xiaowei Chen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 12, 2024
[Cardiovascular safety of sitagliptin added to metformin in real world patients with type 2 diabetes]Zuoxiang Liu, Xiaowei Chen, Houyu Zhao, et al.
Expert Review of Vaccines|December 23, 2021
Self-controlled case series design in vaccine safety: a systematic reviewXiaolu Nie, Lu Xu, Yi Bai, et al.
Frontiers in Pharmacology|July 18, 2022
Risk of Fracture With Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis Combining 177 Randomized Controlled Trials With a Median Follow-Up of 26 weeksSanbao Chai, Fengqi Liu, Zhirong Yang, et al.
Expert Review of Vaccines|July 27, 2023
Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in ChinaRuogu Meng, Rui Ma, Jianmei Wang, et al.
Expert Review of Vaccines|August 23, 2025
Post-marketing surveillance for the safety of the quadrivalent human papillomavirus vaccine: a retrospective real-world study in ChinaRuogu Meng, Rui Ma, Jianmei Wang, et al.
British Journal of Clinical Pharmacology|February 15, 2022
Pharmacovigilance in China: Evolution and future challengesHaibo Song, Xiaojing Pei, Zuoxiang Liu, et al.
Chinese Medical Journal|June 20, 2024
Efficacy and dose-response relationships of antidepressants in the acute treatment of major depressive disorders: a systematic review and network meta-analysisShuzhe Zhou, Pei Li, Xiaozhen Lyu, et al.
Sleep|July 9, 2023
Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysisShuzhe Zhou, Pei Li, Xiaozhen Lv, et al.
International Journal of Endocrinology|June 28, 2022
Serum Cortisol, 25 (OH)D, and Cardiovascular Risk Factors in Patients with Type 2 Diabetes MellitusYuxi Jin, Dandan Wei, Pengling Liu, et al.
Frontiers in Endocrinology|September 11, 2025
Effect of levothyroxine on major adverse cardiovascular events in patients with hypothyroidism and cardiovascular diseaseLijia Liu, Haiqing Zhang, Xiaowei Chen, et al.
Pageof 2